AMAbiotics is a knowledge-based company devoted to research. It rests on the idea of knowledge sharing, and participates to conferences, debates and training with its academic and proprietary competence in biotechnology, systems biology and synthetic biology

 

COST Workshop on Whitefly Metagenomics –Synthetic Biology & Symbiosis

Cavanilles Institute on Biodiversity and Evolutionary Biology
University of Valencia
27-28 february 2012

Valencia, Spain

Functional Analysis for Synthetic Biology. Metabolic Frustration is Driving Compartmentalisation

Presentation

Frontiers in Systems Biology II

Baptist University
The Croucher Foundation
1 - 2 December 2011

Hong Kong, SAR Hong Kong, China

Ageing vs senescence: the fate of the cell factory

Synthetic Biology (SB) puts together two separate entities, a program and a chassis. The majority of SB-related work deals with the program, not the chassis. We will deal with the chassis and ask the quetion: will scaling up synthetic processes be possible, and to what extent? Indeed, scaling up implies reproduction of the chassis, i.e. making similar copies. As in all systems this implies progressive ageing. Living cells have a knack to make that ageing differs from senescence. We will explore how this is possible, and why this has important consequences in terms of SB.

Presentation

Working Seminar in Conceptual Biology

Department of Mathematics
The University of Hong Kong
30 November 2011

Hong Kong, SAR Hong Kong , China

Update of antifragility: a concept used in banking that may be relevant to (synthetic) biology

Bageco11

Bacterial Genetics and Ecology
29 may - 2 June 2011

Kerkyra, Greece

Antifragility: a concept used in banking that may be relevant to (synthetic) biology

Flyer

 

Institut Curie, retreat

Avignon

4 may 2011, 2:30 pm

 

Antifragility: a concept used in banking that may be relevant to (synthetic) biology

 

Beijing Genome Institute

 

 

Shenzhen

6 january 2011, 3:30 pm

 

Functional analysis in genome sequence annotation
with an introduction on the arsenic nightmare, and the way science should not be done, or "why thinking as an engineer helps making discoveries"

Croucher Advanced Study Institute

Faculty of Medicine HKU

5 january 2011, 4:30 pm

 

Synthetic biology and aging

Hong Kong University of Science and Technology

 

 

 

Biochemistry and Cell Biology

5 january 2011, 10 am

 

Antifragility; a novel view of finances that may be used in modelling metabolism

The University of Hong Kong

Li Ka Shing Faculty of Medicine

Department of Biochemistry

4 january 2011, 4 pm

 

Stability requirements for efficient metabolic engineering

 

 

European Technology Assessment Group

Making perfect life

Bio-engineering in the 21st Century

10 november 2010, European Parliament, 1-6 pm

Public debate      Programme  

 

LIX Ecole Polytechnique

LIX - BioInformatics Colloquium 2010

8 november 2010, 5 15 - 6 15 pm

 

Reproduction vs replication: a role for Maxwell's demon

TARPOL summer school on synthetic biology

Metabolic and spatial frustration as contraints for synthetic biology

27 september 2010
ETH Zürich, Basel, Switzerland

 

 

Presentation
(1.8 Mb)

 

International workshop on synthetic biology

Interfacing biology, technology and society

Molecular traffic jams and the reproduction vs replication dilemma

25-27 august 2010
Copenhagen, Denmark

 

 

Presentation
(1.2 Mb)

 

The US-EC task force in biotechnology research

Exploratory workshop: Toward standards in synthetic biology

Molecular traffic jams and emergence of metabolic and regulatory conflicts

4-6 june 2010
Segovia, Spain

 

Report

The Third Schmid Training Course

International training course

The body plan, an information trapped by Maxwell's demons?

10-14 may 2010
Station Biologique de Roscoff, Roscoff, France

Belgian Society for Microbiology

Interfacing Systems Biology and Synthetic Biology

25 march 2010
Palais des Académies
1, rue Ducale, Brussels, Belgium

 

 

Presentation
(1.1 Mb)

 

In a context where industry invests considerable hopes and means in a discipline presented as a new domain of research, Synthetic Biology, we must explore the pros and cons to make motivated choices. The lecture aimed at showing that it is not sufficient to make promises to succeed, and that specific constraints linked to biology have to be taken into account. These constraints where metabolism, ageing and invention have a malor role, will decide of the future successes of Synthetic Biology. Living organisms behave as information gathering and reproducing systems, and this has considerable consequences on their evolution. The economic model of AMAbiotics is constructed with this perspective in mind.